Characteristics, treatment of radiation-induced hair loss in cancer patients

August 05, 2020

What The Study Did: Characteristics and response to treatment of persistent radiation-induced hair loss in patients with primary central nervous system tumors or head and neck cancer were examined in this observational study.

Authors: Mario E. Lacouture, M.D., of Memorial Sloan Kettering Cancer Center in New York, is the corresponding author.

To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/

(doi:10.1001/jamadermatol.2020.2127)

Editor's Note: The article includes conflict of interest and funding/support disclosures. Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

#  #  #

Media advisory: The full study is linked to this news release.

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamadermatology/fullarticle/10.1001/jamadermatol.2020.2127?guestAccessKey=e7913afe-bfb4-46f6-9d5b-4a4c5bdfee13&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=080520
-end-


JAMA Dermatology

Related Neck Cancer Articles from Brightsurf:

Head and neck cancer patients benefited from Affordable Care Act
The rate of uninsured patients with head and neck cancers was 'significantly reduced' following the implementation of the federal Patient Protection and Affordable Care Act (ACA).

Insurance coverage among patients with head/neck cancer after ACA
Researchers investigated the association between the Affordable Care Act and changes in the percentage of patients with insurance among 130,000 people with head and neck cancer across varying socioeconomic and demographic backgrounds.

Skin cancer above the neck more likely to spread, research shows
Forty-five patients with new diagnoses of MM were investigated over a period of 6 months and were divided into two groups of patients, with above neck MM and below neck MM.

How cigarette smoke makes head and neck cancer more aggressive
A change in the tumor metabolism due to tobacco exposure could open new treatment avenues in head and neck cancer.

Testing therapies on mini-tumors of head and neck cancer
Head and neck cancer is an aggressive type of cancer that often recurs, despite patients undergoing harsh treatments.

Comparing financial burdens of head and neck cancer with other cancers
Head and neck cancer is expensive to treat and the disease can create long-term health needs.

Opioid use and misuse following treatment for head and neck cancer
Six months after treatment ended, 7 percent of patients remained on opioid pain medications.

Study: Immunotherapy better than chemotherapy for subtype of head and neck cancer
A randomized clinical trial involving 97 medical centers in 20 countries, including Moores Cancer Center at UC San Diego Health, found that treating patients with head and neck cancer with the immunotherapy drug pembrolizumab is more effective and less toxic than standard chemotherapy.

Immunotherapy keeps some advanced head and neck cancer patients alive for over three years
A new immunotherapy can greatly extend the lives of a proportion of people with advanced head and neck cancer, with some living for three years or more, a major new clinical trial reports.

Head and neck cancer survivors at increased risk of suicide
Despite improved survival rates among cancer patients, the risk of death by suicide remains high, especially among those treated for head and neck cancers.

Read More: Neck Cancer News and Neck Cancer Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.